Kangmei Pharma | 600518 - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Akebia Therapeutics USD 427M 297M 2025-12
Alaunos Therapeutics USD 7M 2M 2026-03
Avita Medical AUD 105.47M 35.32M 2025-12
Cspc Pharmaceutical CNY 103.79B 16.5B 2026-03
Dianthus Therapeutics USD 4.58B 2.8B 2026-03
Genomma Lab Internacional MXN 15.03B 3.09B 2026-06
Hypermarcas BRL 16.38B 1.46B 2026-03
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
IQVIA Holdings USD 32.25B 3.62B 2026-06
Jiangsu Hengrui CNY 344.89B 22.02B 2026-06
Kangmei Pharma CNY 24.48B 3.45B 2026-03
Organon & Co USD 3.56B 1.99B 2026-06
Revvity USD 12.69B 2.75B 2026-06
Tectonic Therapeutic USD 580M 190M 2026-03
Viatris USD 18.49B 2.76B 2026-06
Xeris Pharmaceuticals USD 1000M 303M 2026-03
Zz Pientze Pharmaceu CNY 65.93B 25.23B 2026-06